cystic-fibrosis

Documents about cystic-fibrosis

• Cell Content of Sputum Induced by Hypertonic Saline in Adolescents With Cystic Fibrosis#897812ClinicalTrials.gov
• Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis#907063ClinicalTrials.gov
• Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis#910040ClinicalTrials.gov
• The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients#968367ClinicalTrials.gov
• Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis#969232ClinicalTrials.gov
• A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis#1007956ClinicalTrials.gov
• Medication adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: Analysis on the French cystic fibrosis population from 2012 to 2020#250281HAL (France)
• GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance#803713ClinicalTrials.gov
• Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis#853604ClinicalTrials.gov
• Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis#804437ClinicalTrials.gov
• Patient-reported outcome measures developed for non-cystic fibrosis bronchiectasis may be applied to cystic fibrosis bronchiectasis.#213900NCBI PubMed Central
• A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection#256905ClinicalTrials.gov
• Pathogenicity of Species of the Achromobacter Genus in Patients From Reunion Island With Cystic Fibrosis#283062ClinicalTrials.gov
• Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis#805952ClinicalTrials.gov
• Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis#812047ClinicalTrials.gov
• Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age#835864ClinicalTrials.gov
• Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.#860976ClinicalTrials.gov
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis#873021ClinicalTrials.gov
• Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis#874143ClinicalTrials.gov
• Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation#877115ClinicalTrials.gov
• Evaluation of Patient Access to People With Cystic Fibrosis (CF) and Healthcare Professionals#892663ClinicalTrials.gov
• The Application of the Self Care Deficit Nursing Theory in Adolescents With Cystic Fibrosis#901796ClinicalTrials.gov
• Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis.#909538ClinicalTrials.gov
• Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)#911701ClinicalTrials.gov
• Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis Patients#916228ClinicalTrials.gov
• Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis Patients#968889ClinicalTrials.gov
• Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens#1009355ClinicalTrials.gov
• Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis#226301ClinicalTrials.gov
• Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis#230457ClinicalTrials.gov
• Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis#803073ClinicalTrials.gov
• Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis#825654ClinicalTrials.gov
• Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection#828981ClinicalTrials.gov
• Interactive Video Game Responses in Cystic Fibrosis#829540ClinicalTrials.gov
• Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients#829859ClinicalTrials.gov
• Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population#833338ClinicalTrials.gov
• Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis#836518ClinicalTrials.gov
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients#843127ClinicalTrials.gov
• Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age#861770ClinicalTrials.gov
• Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase#872852ClinicalTrials.gov
• Bone Microarchitecture in Young Cystic Fibrosis Patients#873579ClinicalTrials.gov
• A Coaching Intervention to Young Adults With Cystic Fibrosis#912621ClinicalTrials.gov
• The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis#915518ClinicalTrials.gov
• Cystic Fibrosis Blood Neutrophils#980752ClinicalTrials.gov
• Remote Exercise to Improve Physical Activity Levels and Markers of Heart Health in Cystic Fibrosis (RHH-CF)#886892ClinicalTrials.gov
• Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa#898219ClinicalTrials.gov
• Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function#152372ClinicalTrials.gov
• Use of a Portable Spirometer in Pediatric Patients With Cystic Fibrosis at the Nancy CHRU: Feasibility Study#172477ClinicalTrials.gov
• Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)#195352ClinicalTrials.gov
• Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center#287474ClinicalTrials.gov
• Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis#291017ClinicalTrials.gov